Glenmark Sued By Cephalon For Treanda Generic Plans
This article was originally published in PharmAsia News
Executive Summary
Glenmark Pharmaceuticals said it and its U.S. unit have been sued by Cephalon for patent infringement of its Treanda (bendamustine) drug for treating leukemia.